Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

37
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
37
Separation of Sister Chromatids02:17

Separation of Sister Chromatids

3.7K
At the transition from prophase to metaphase, there is a reduction in cohesion along the chromosomal arms, resulting in the resolution of sister chromatids. However, residual cohesin connections remain to hold the sister chromatids together until the transition from metaphase to anaphase. The residual connection prevents any premature separation of sister chromatids, blocking the risks of aneuploidy within the daughter cells.
At the onset of anaphase, separase, a proteolytic enzyme, is...
3.7K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

19
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
19
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

27
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
27

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Distribution, typology and specificity of pediatric polytrauma centers in Italy.

Frontiers in surgery·2026
Same author

Use of Tramadol in Pain Management of Neonates with Epidermolysis Bullosa: A Single-Center Experience.

Children (Basel, Switzerland)·2026
Same author

Prenatal assessment of diaphragmatic defect size in left-sided congenital diaphragmatic hernia using a novel MRI-based parameter for outcome prediction: the Defect-to-HEmithorax Ratio (DHER).

American journal of obstetrics & gynecology MFM·2026
Same author

Prenatal ultrasound diagnosis, intrauterine monitoring and postnatal management of a giant fetal abdominopelvic lymphangioma: a case report and scoping review.

Frontiers in pediatrics·2026
Same author

Editorial: Advances and challenges in neonatal surgery: congenital and acquired conditions.

Frontiers in pediatrics·2026
Same author

Thoracoscopic versus open congenital diaphragmatic hernia repair: a systematic review and meta-analysis by the Pediatric Surgery Meta-Analysis Study Group (PESMA).

Pediatric surgery international·2026
Same journal

Establishment of a CT-based prediction model for endotracheal tube size in infants aged <1 year.

Frontiers in pediatrics·2026
Same journal

Case Report: Subcutaneous sensor-augmented insulin pump therapy in a 510-g preterm infant with hyperglycemia.

Frontiers in pediatrics·2026
Same journal

Association between glucolipid metabolic indicators and the risk of suspected precocious puberty in children living with obesity: a retrospective cohort study.

Frontiers in pediatrics·2026
Same journal

Clinical and imaging features of tufted angioma in children.

Frontiers in pediatrics·2026
Same journal

Transcriptome-Inferred metabolic subtypes define prognostic and immune ecosystems in osteosarcoma at single-cell resolution.

Frontiers in pediatrics·2026
Same journal

Efficacy and anthropometric predictors of negative-pressure therapy for recurrent concealed penis in pediatric patients.

Frontiers in pediatrics·2026
See all related articles

Related Experiment Video

Updated: Aug 21, 2025

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn
11:27

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn

Published on: April 7, 2023

6.4K

Unsolved problems in CDH follow-up.

Laura Valfré1, Andrea Conforti1, Francesco Morini2

  • 1Neonatal Surgery Unit, Medical and Surgical Department of Fetus-Newborn-Infant, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Frontiers in Pediatrics
|November 17, 2022
PubMed
Summary
This summary is machine-generated.

Improved survival in congenital diaphragmatic hernia (CDH) patients highlights the growing challenge of late-onset comorbidities. Addressing these complex, long-term health issues is crucial for ongoing CDH care and management.

Keywords:
congenital diaphragmatic hernia (CDH)hearing losslong-term follow-upneurodevelopmentproblemspulmonary hypertensionthoracoscopy

More Related Videos

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
08:22

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

Published on: December 1, 2017

8.7K
Detection of a CDH1 Rare Transcript Variant in Fresh-frozen Gastric Cancer Tissues by Chip-based Digital PCR
09:16

Detection of a CDH1 Rare Transcript Variant in Fresh-frozen Gastric Cancer Tissues by Chip-based Digital PCR

Published on: February 5, 2018

6.3K

Related Experiment Videos

Last Updated: Aug 21, 2025

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn
11:27

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn

Published on: April 7, 2023

6.4K
A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
08:22

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

Published on: December 1, 2017

8.7K
Detection of a CDH1 Rare Transcript Variant in Fresh-frozen Gastric Cancer Tissues by Chip-based Digital PCR
09:16

Detection of a CDH1 Rare Transcript Variant in Fresh-frozen Gastric Cancer Tissues by Chip-based Digital PCR

Published on: February 5, 2018

6.3K

Area of Science:

  • Pediatric Surgery
  • Neonatology
  • Pulmonology

Background:

  • Advances in technology and pharmacology have increased survival rates for patients with congenital diaphragmatic hernia (CDH) beyond the neonatal period.
  • This improved survival has shifted the focus towards managing complex late-onset comorbidities in CDH patients.

Purpose of the Study:

  • To highlight critical "unsolved problems" in the long-term follow-up care of CDH patients.
  • To emphasize the increasing importance of addressing late morbidity in CDH management.

Main Methods:

  • This paper is a review and discussion of existing challenges.
  • It synthesizes current knowledge on late comorbidities in CDH.

Main Results:

  • CDH survivors frequently face chronic pulmonary and cardiac dysfunctions.
  • Neurodevelopmental challenges and specific nutritional requirements are common.
  • These conditions often necessitate prolonged medical or surgical interventions.

Conclusions:

  • Late morbidity is a significant and growing concern in CDH patient care.
  • Further research and clinical strategies are needed to address the "unsolved problems" in long-term CDH follow-up.
  • Optimizing long-term outcomes requires a comprehensive approach to managing chronic comorbidities.